June 2016
Preclinical Pathfinder and Araim Pharmaceutical ( New York) entered into an agreement to start preclinical development for a new cancer therapy.
June 2016
Preclinical Pathfinder and Araim Pharmaceutical ( New York) entered into an agreement to start preclinical development for a new cancer therapy.